The health insurance industry’s trade association, along with other organizations, sent a letter to the FDA arguing that different names could lead to prescriber confusion and medication errors.
Five things for pharma marketers to know, Thursday, June 4
Celltrion expects its Remicade biosimilar to hit the US this year; Vivus cuts its sales force; BMJ accuses Novartis of interfering with clinical trials
Doctors want specifics on biosimilar labels
March 24, 2015
4:00 pm
An Alliance for Safe Biologic Medicines survey shows what doctors mean by biosimilar transparency.
Biosimilar uptake will require companies to tell a trustworthy backstory
Achillion’s experimental HCV drug cleared the virus in six weeks when combined with Gilead’s Sovaldi; Sanofi will replace a third of its sales managers; GSK shutters Montana vaccine R&D.
AI Deciphered: Discovering the Potential for Marketers and Communicators